Ling Cao

Ling Cao

Auto-generated profile, based on publicly available information

Ling Cao

Department of Biomedical Sciences, University of New England College of Osteopathic Medicine

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2018 in BMC Public Health
Verified
Journal Article
Open access
PDF file
JMJennifer Malon
Jennifer Malon
PSParth Shah
Parth Shah
WKWoon Yuen Koh
Woon Yuen Koh
GCGary Cattabriga
Gary Cattabriga
ELEdward Li
Edward Li
LCLing Cao
Ling Cao
Chronic pain is currently a significant health problem in the United States. A comprehensive strategy is needed to increase prevention of chronic pain and to improve care for chronic pain patients. However, development of a successful strategy relies, in part, on a better understanding of the demographics and socioeconomics of patients living with chronic pain conditions. The current study was designed to understand the burden of chronic pain in the state of Maine by identifying the prevalence of chronic pain and its relationship with selected demographic and socioeconomic factors in Maine. The Maine All Payer Claims Database (MEAPCD) (2006–2011) was used in the secondary data analysis to assess the demographic characteristics (such as age, sex, insurance type, and county of residence) of chronic pain patients in Maine. Chronic pain patients were identified based on the presence of pre-identified chronic pain-associated ICD-9 code(s) and opioid prescription information. Potential associations between the prevalence of chronic pain and a number of socioeconomic factors were determined by comparisons to Maine Census data. More women in the state were identified as having chronic pain across all counties and all age groups (> 10 years old). Surprisingly, the majority of chronic pain patients were identified based on the diagnostic code criteria and not the opioid prescription criteria. A greater utilization of public health insurance was seen within the chronic pain patients. At the county level, although neither education level nor income were associated with the prevalence of chronic pain, these factors significantly correlated with the usage of public health insurance. Further detailed characterization of the chronic pain patient population in the state of Maine, using multiple data sources, can help design population-targeted strategies to prevent and manage chronic pain.

1 December 2009 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
LCLing Cao
Ling Cao
CPChristopher D. Palmer
Christopher D. Palmer
JMJennifer T. Malon
Jennifer T. Malon
JLJoyce A. De Leo
Joyce A. De Leo
We recently demonstrated a contributing role of spinal cord infiltrating CD4+ T lymphocytes in the maintenance of mechanical hypersensitivity in a rodent model of neuropathic pain, spinal nerve L5 transection (L5Tx). It has been demonstrated that microglia play a role in the etiology of pain states. We hypothesized that infiltrating CD4+ T lymphocytes communicate with microglia via a CD40‐CD154 interaction. Here, we investigated the role of CD40 in the development of mechanical hypersensitivity post‐L5Tx. CD40 KO mice displayed significantly decreased mechanical sensitivity compared with WT mice starting from day 5 post‐L5Tx. Using bone marrow chimeric mice, we further identified a pro‐nociceptive role of CNS microglial CD40 rather than the peripheral leukocytic CD40. Flow cytometric analysis determined a significant increase of CD40+ microglia in the ipsilateral side of lumbar spinal cord post‐L5Tx. Further, spinal cord proinflammatory cytokine (IL‐1β, IL‐6, IL‐12, and TNF‐α) profiling demonstrated an induction of IL‐6 in both WT and CD40 KO mice post‐L5Tx prior to the increase of microglial CD40 expression, indicating a CD40‐independent induction of IL‐6 following L5Tx. These data establish a novel role of microglial CD40 in the maintenance of nerve injury‐induced behavioral hypersensitivity, a behavioral sign of neuropathic pain.

1 March 2016 in Biomolecules & Therapeutics
Verified
Journal Article
Open access
YSYusheng Shu
Yusheng Shu
YLYu Liu
Yu Liu
XLXinxin Li
Xinxin Li
LCLing Cao
Ling Cao
XYXiaolong Yuan
Xiaolong Yuan
QCQianqian Cao
Qianqian Cao
The endothelial-mesenchymal transition (EndMT) is known to be involved in the transformation of vascular endothelial cells to mesenchymal cells. EndMT has been confirmedthat occur in various pathologic conditions. Transforming growth factor β1 (TGF-β1) is a potent stimulator of the vascular endothelial to mesenchymal transition (EMT). Aspirin-triggered resolvin D1 (ATRvD1) has been known to be involved in the resolution of inflammation,but whether it has effects on TGF-β1-induced EndMT is not yet clear. Therefore, we investigated the effects of AT-RvD1 on the EndMT of human umbilical vein vascular endothelial cells line (HUVECs). Treatment with TGF-β1 reduced the expression of Nrf2 and enhanced the level of F-actin, which is associated with paracellular permeability. The expression of endothelial marker VE-cadherin in HUVEC cells was reduced, and the expression of mesenchymal marker vimentin was enhanced. AT-RvD1 restored the expression of Nrf2 and vimentin and enhanced the expression of VE-cadherin. AT-RvD1 did also affect the migration of HUVEC cells. Inhibitory κB kinase 16 (IKK 16), which is known to inhibit the NF-kB pathway, had an ability to increase the expression of Nrf2 and was associated with the inhibition effect of AT-RvD1 on TGF-β1-induced EndMT, but it had no effect on TGF-β1-induced EndMT alone. Smad7, which is a key regulator of TGF-β/Smads signaling by negative feedback loops, was significantlyincreased with the treatment of AT-RvD1. These results suggest the possibility that AT-RvD1 suppresses the TGF-β1-induced EndMT through increasing the expression of Smad7 and is closely related to oxidative stress.

1 February 2018 in Neuroscience
Verified
Journal Article
Closed access
LCLing Cao
Ling Cao
JMJennifer T. Malon
Jennifer T. Malon


1 October 2012 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
LCLing Cao
Ling Cao
MBM. Brady Butler
M. Brady Butler
LTLeonard Tan
Leonard Tan
KDKyle S. Draleau
Kyle S. Draleau
WKWoon Yuen Koh
Woon Yuen Koh
Distal symmetrical polyneuropathy is the most common form of HIV infection-associated peripheral neuropathy and is often associated with pain. C57BL/6 (B6) mice infected with LP-BM5, a murine retroviral isolate, develop a severe immunodeficiency syndrome similar to that in humans infected with HIV-1, hence the term murine AIDS. We investigated the induction of peripheral neuropathy after LP-BM5 infection in B6 mice. Infected B6 mice, like HIV-infected humans, exhibited behavioral (increased sensitivity to mechanical and heat stimuli) and pathological (transient loss of intraepidermal nerve fibers) signs of peripheral neuropathy. The levels of viral gag RNA were significantly increased in all tissues tested, including spleen, paw skin, lumbar dorsal root ganglia, and lumbar spinal cord, postinfection (p.i.). Correlated with the development of peripheral neuropathy, the tissue levels of several cytokines, including IFN-γ, IL-1β, IL-6, and IL-12, were significantly elevated p.i. These increases had cytokine-specific and tissue-specific profiles and kinetics. Further, treatment with the antiretroviral agent zidovudine either significantly reduced or completely reversed the aforementioned behavioral, pathologic, and cytokine changes p.i. These data suggest that LP-BM5 infection is a potential mouse model of HIV-associated distal symmetrical polyneuropathy that can be used for investigating the roles of various cytokines in infection-induced neuropathic pain. Further investigation of this model could give a better understanding of, and lead to more effective treatments for, HIV infection-associated painful peripheral neuropathy.